Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gerald via Twitter this AM
(from another board... just putting the info out... don't shoot the messenger)
Todos Medical Achieves Medical Importer Status with US FDA
http://www.globenewswire.com/news-release/2020/04/15/2016435/0/en/Todos-Medical-Achieves-Medical-Importer-Status-with-US-FDA.html
Posting this news because of Amarantus holdings in Todas Medical. Should impact value of AMBS shares if Todas is successful with their COVID-19 plans. GLTA
Gotta love it when the stock is up all day on decent volume and drops in the red on the last 100 share trade of the day.
I'm guessing you are one of the lucky few who made money on this investment, which is why you feel qualified to call anyone else who invested a dolt. Or did you lose money and are therefore a dolt as well?
Just asking a simple question. You seem pretty bitter towards the CEO. Must be some hard lesson there, which implies you lost a lot of money.
The posts you made about Todos and COVID-19 tests are off topic as well. TIA
FDA news this week, I expect.
Todos had about 72M issued at end of 2018. Don't know the current number. Doesn't matter. I'm invested in Todos for the short-term, nothing more. Don't know about AMBS; not an investor.
Todos Medical Expands on Coronavirus (COVID-19) Distribution Agreement with Shanghai Liangrun Subsidiary Gibraltar
https://finance.yahoo.com/news/todos-medical-expands-coronavirus-covid-134246524.html
Good for Abbott Labs. However, with the demand already demonstrated for these rapid tests, as well as the need for multiple tests per person over the next 12 months described by numerous medical professionals, it seems very unlikely Abbott Labs will be able to come close to meeting the demand at a production rate of 50,000 tests per day. Demand is expected to be in the hundreds of millions of quick tests in the USA alone, thereby creating an opportunity for many different companies to participate in meeting that demand. Maybe Todos will be successful in their endeavor, maybe not.
I'm more pleased about these tests becoming available to help people in need than I am in making a few bucks with an investment, although I hope that happens as well.
Thanks for the story. Certainly great news for all Americans, and kudos to Abbott Labs.
Buying as well.
Kinda like when your posts paint TOMDF as on "Top of the World" one day, and the next day your posts indicate the company is in Jack's dilemma, stuck in the freezing North Atlantic and doomed to sink to the bottom.
Except here, YOU are the bitch. How is anyone expected to believe anything you post, with such shifting outlooks on the stock?
Care to address your misinformation post about FDA approval requiring 2 years when the company is pursuing approval under UEA rules?
It doesn't take 2 years for FDA approval under the Emergency Use Authorization (EUA), which is identified in every press release regarding the test kits. Intentional misinformation? Scare tactic, perhaps?
Opinions vary.
It appears CLIA testing is no longer a requirement following the latest FDA policy update. Perhaps there are reasons I'm not aware of for pursuing the CLIA route at Provista's Lab, but it seems the EUA route would bring the product to doctors clinics faster than CLIA certification.
FDA Update
Coronavirus (COVID-19) Update: FDA Provides More Regulatory Relief During Outbreak, Continues to Help Expedite Availability of Diagnostics
With the highly contagious nature of COVID-19, I expect testing will be ongoing and individuals will have to be tested multiple times while we wait on development of an effective vaccine.
I don't believe we know with any certainty if a person can be re-infected after they've already contracted and recovered from the virus. Routine testing may be a critical element to prevent infecting those most susceptible to the virus (elderly, those with suppressed immune systems, etc.). A lot of test kits will be needed. Perhaps Todos can provide a large percentage of the kits needed if the Chinese manufacturing capacity of the test kits is accurately stated in the news release.
FDA approval is not required for COVID-19 diagnostic tests. Individual states can authorize use of tests for screening residents.
FDA Provides More Regulatory Relief During Outbreak, Continues to Help Expedite Availability of Diagnostics
The kit AYTU is promoting is not a "home, self-test kit". The CEO clearly states in his interview this test will be conducted at your healthcare providers office. This is so the results can be properly interpreted and medical advice can be given to the patient based on those results.
There are many here who spread misinformation, both positive and negative. We would all be wise to stick to what is published in reputable sources and base our decisions on that info, not what we read on a stock message board.
Wouldn't I get a similar result (larger buys and sells) simply by increasing the SAFE value from the current 10% to say, 12 or 15%? This should result in fewer trades for larger number of shares when the trigger is hit.
I've never thought much of market timing schemes or encountered one that consistently predicted the market that would outperform DCA over the long term.
But I'll still look into Wilders RSI. Thanks for the suggestion.
I set Buy and Sell GTC orders at 10% above or below PC (SAFE = 10%). I don't recall setting a minimum purchase amount beyond the 10% difference calculated (can't review since I deleted it). This was the first attempt just to get an idea of performance vs. buy-and-hold. There could certainly be some optimization applied.
In reality, I will likely dollar cost average into this investment while using AIM, probably $1000/month over the next 12 years.
I read Lichello's book back in the 80's, modeled it with some mutual funds decades ago (back when I had to look up the prices on library microfilm) but never put it into use. It was hard to find a fund that had enough volatility to beat the buy-and-hold or dollar cost averaging approach. Some of the ETFs available today seem to provide the volatility needed to make this algorithm viable.
Any recommendations for AIM settings (and reasoning behind) would be appreciated.
Hi Tom.
How would someone obtain the Newport program for AIM management? Is it still available for sale (probably unlikely)? I have an old laptop I could easily configure for AIM-only use.
I just started investing $40K a year in my Roth IRA using the Mega Backdoor Roth IRA strategy and I'd like to use some of those funds to invest in TQQQ with AIM management. I created a spreadsheet to test the AIM strategy with initial $10K investment using 75/25 split in shares/cash. Over a recent 5-year period, the AIM model generated 28% annual return vs. 34% for buy-and-hold. In that 5-year period test, ran out of cash several times, but have been reading up on your Vealie approach and want to test again after implementing that feature.
I could handle the AIM method with the spreadsheet approach, but would be interested to take a look if there's still a way to get the Newport software.